TScan Therapeutics, Inc. - COM (TCRX)

Historical Portfolio Holders from Q3 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
34.1 M
Holdings value Q1 2024
$271 M
Value change Q1 2024
+$19.2 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
64
Number of buys Q1 2024
38
Number of sells Q1 2024
-13
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
89854M101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 34.1 M $271 M +$19.2 M $7.94 64
2023 Q4 31.7 M $185 M +$7.36 M $5.83 53
2023 Q3 28.6 M $73.2 M +$2.18 M $2.56 32
2023 Q2 28 M $69.9 M +$45.8 M $2.50 28
2023 Q1 9.65 M $20.3 M +$610 K $2.10 27
2022 Q4 9.52 M $14.8 M -$121 K $1.55 28
2022 Q3 9.51 M $29 M -$531 K $3.05 24
2022 Q2 9.68 M $30.4 M +$1.53 M $3.14 23
2022 Q1 9.37 M $26.2 M -$1.53 M $2.80 23
2021 Q4 9.86 M $44.4 M -$2.46 M $4.50 28
2021 Q3 10.1 M $83.5 M +$83.5 M $8.34 26